4.2 Review

Toxicity profile of patients treated with proton and carbon-ion therapy for primary nasopharyngeal carcinoma: A systematic review and meta-analysis

期刊

出版社

WILEY
DOI: 10.1111/ajco.13915

关键词

carbon ion therapy; heavy ion radiotherapy; meta-analysis; nasopharyngeal carcinoma; proton therapy; treatment outcome

类别

向作者/读者索取更多资源

This study aimed to synthesize the data on the toxicity outcomes of proton and carbon-ion therapy for primary nasopharyngeal carcinoma (NPC). The analysis of 12 studies showed that particle beam therapy (PBT) had better outcomes in terms of acute toxicities, possibly due to reduced dose to critical structures.
BackgroundProton and carbon-ion therapy may spare normal tissues in regions with many critical structures surrounding the target volume. As toxicity outcome data are emerging, we aimed to synthesize the published data for the toxicity outcomes of proton or carbon-ion therapy (together known as particle beam therapy [PBT]) for primary nasopharyngeal carcinoma (NPC). Materials and methodsWe searched PubMed and Scopus electronic databases to identify original studies reporting toxicity outcomes following PBT of primary NPC. Quality assessment was performed using NIH's Quality Assessment Tool. Reports were extracted for information on demographics, main results, and clinical and dose factors correlates. Meta-analysis was performed using the random-effects model. ResultsTwelve studies were selected (six using mixed particle-photon beams, five performed comparisons to photon-based therapy). The pooled event rates for acute grade >= 2 toxicities mucositis, dermatitis, xerostomia weight loss are 46% (95% confidence interval [95% CI]-29%-64%, I-2 = 87%), 47% (95% CI-28%-67%, I-2 = 87%), 16% (95% CI-9%-29%, I-2 = 76%), and 36% (95% CI-27%-47%, I-2 = 45%), respectively. Only one late endpoint (xerostomia grade >= 2) has sufficient data for analysis with pooled event rate of 9% (95% CI-3%-29%, I-2 = 77%), lower than intensity-modulated radiotherapy 27% (95% CI-10%-54%, I-2 = 95%). For most endpoints with significant differences between the PBT and photon-based therapies, PBT resulted in better outcomes. In two studies where dose distribution was studied, doses to the organs at risk were independent risk factors for toxicities. ConclusionPBT may reduce the risk of acute toxicities for patients treated for primary NPC, likely due to dose reduction to critical structures. The pooled event rate for toxicities derived in this study can be a guide for patient counseling.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据